Common Sensing is a Cambridge, MA-based, evidence-based, data-driven injectable-medicine healthcare company founded in 2012. It was co-founded by James White and Richard Whalley and is led operationally by COO Kevin Schmid. The company is advancing Gocap, an IP-protected smart cap that tracks, logs and manages injectable dosage, timing, and storage to provide a complete picture of how people use injectable medicine at home and on the go. Gocap enables patients and providers to utilize injectable medicines including insulin, fertility medications, and growth hormones. Common Sensing offers data-driven services such as remote disease management, pharmaceutical support, automatic refills, dose titration, and caretaker collaboration. It recently closed a $6.6M Series A to accelerate manufacturing and commercial operations for Gocap.

Total raised

$7M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2018